Unlock instant, AI-driven research and patent intelligence for your innovation.

Engineered ketoreductase polypeptide and method for preparing montelukast midbody by means of same

A compound, ketopropyl technology, applied in the field of engineered ketoreductase polypeptides and preparation of montelukast intermediates, can solve the problems of low substrate concentration, long reaction time, poor atom economy, etc., and achieve the substrate concentration High, overcoming the effect of poor reaction performance and short reaction time

Inactive Publication Date: 2016-10-12
ENZYMEWORKS
View PDF8 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

(-)-DIP-Cl has problems such as poor atom economy, cumbersome operation steps, complicated separation, and serious pollution.
Biotransformation methods such as Org.Process Res.Dev.2010,14,193 and WO 2009 / 042984A1 reported that the method has a high amount of enzyme (3%), long reaction time (24h), low substrate concentration (12%) and Problems such as high amount of organic solvent (60%)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Engineered ketoreductase polypeptide and method for preparing montelukast midbody by means of same
  • Engineered ketoreductase polypeptide and method for preparing montelukast midbody by means of same
  • Engineered ketoreductase polypeptide and method for preparing montelukast midbody by means of same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Embodiment 1 (preparation of ketoreductase):

[0021] A ketoreductase catalyst was prepared using conventional methods: Sequence in the table 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 gene fragments were provided by Suzhou Jinweizhi Biology Synthesized by Science and Technology Co., Ltd., connected with pET30a (Novagen) plasmid enzyme digestion product, transformed into competent E.coli BL21 (DE3) strain, screened to obtain positive clones, inoculated into liquid LB medium containing resistance, at 37 Cultivate at ℃ until OD600 to 0.8, add inducer IPTG, continue to cultivate for 16 hours, centrifuge to collect the precipitate, add phosphate buffer to suspend, ultrasonically break in ice-water bath for 10 minutes, centrifuge to take the supernatant, and freeze to obtain ketoreductase enzyme powder.

Embodiment 2

[0022] Embodiment 2 (screening of ketoreductase)

[0023] By sequence 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 respectively in Escherichia coli Ketoreductase 2 mg obtained by expression, glucose dehydrogenase (purchased from Suzhou Hanzyme Biotechnology Co., Ltd., brand EW002) 2 mg, NADP 1 mg, substrate 2-(3-(3-((E)-2-(7 -Chloroquinolinyl)vinyl)phenyl)-3-ketopropyl)methyl benzoate 50mg and glucose 50mg were added to a 5mL reactor containing 2mL 0.05M triethanolamine buffer solution, stirred at 30°C at 1000rpm, after 1h Sampling by HPLC showed that the conversion rate and ee of sequence 43 were both >99%, so sequence 43 was used as the object of further research.

Embodiment 3

[0024] Embodiment 3 (enzyme catalyzed reaction):

[0025] Add 100 mg of ketoreductase (obtained by expression of sequence 43 in Escherichia coli), 20 mg of glucose dehydrogenase (purchased from Suzhou Hanzyme Biotechnology Co., Ltd., brand EW002) and 5 mg of NADP triethanolamine buffer into a 50 mL three-necked reaction flask in sequence. solution, 5g substrate 2-(3-(3-((E)-2-(7-chloroquinolinyl)vinyl)phenyl)-3-ketopropyl)methyl benzoate, 3.5g glucose, 20mL 0.05M pH 7.0 triethanolamine buffer, 5mL toluene, temperature adjusted to 30°C, stirring at 900r / min, 15%Na 2 CO 3 The pH of the solution was maintained at 7.0, reacted for 12 hours, and the conversion rate was 99% as detected by HPLC, added 30ml of methanol, refluxed at 60°C for 2h, filtered and added deionized water dropwise to the filtrate until no solid precipitated, filtered to take the filter cake and added at 60°C After the methanol was just dissolved, deionized water was added dropwise until no solid precipitated,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an engineered ketoreductase polypeptide and a method for preparing a montelukast midbody by means of the same. Compared with the prior art, the engineered ketoreductase polypeptide has the advantages that enzyme consumption is low, reaction time is short, substrate concentration is high, and the engineered ketoreductase polypeptide is more suitable for industrial application when used for preparation of the montelukast midbody.

Description

technical field [0001] The invention relates to the technical fields of biopharmaceuticals and biotransformation, in particular to an engineered ketoreductase polypeptide and a method for preparing a montelukast intermediate. Background technique [0002] Montelukast (CAS No. 158966-92-8) is a selective leukotriene receptor antagonist (LTRA) with significant market value for the prevention and treatment of asthma, bronchoconstriction and allergic rhinitis . The molecular structure patent of Monteluster expired on August 3, 2012, so it can effectively synthesize its active ingredient 2-(3-(3-((E)-2-(7-chloroquinolinyl)vinyl) ) phenyl)-(3S)-3-hydroxypropyl) methyl benzoate method has broad application prospects. A common synthetic route is shown in the following formula: [0003] [0004] Utilize (-)-diisopine-pinocampylchloroborane catalyst ((-)-DIP-Cl) in the chemical process to carry out asymmetric hydrogenation catalysis (J.Am.Chem.Soc.1996,118,2521 and WO 2008 / 0099...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/04C12N15/53C12P17/12
CPCC12N9/0006C12P17/12
Inventor 原海亮
Owner ENZYMEWORKS